Catalyst Funds Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,700
Closed -$234K 1502
2024
Q2
$234K Buy
+1,700
New +$234K 0.06% 190